Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| REPLIGEN CORP | 150,000 | reported | 28 Feb 2013 | tx 1+40,000 |
| Ocugen, Inc. | 110,000 | reported | 01 Oct 2018 | tx 15+671,000−348,000 |
| Altus Pharmaceuticals Inc. | 45,000 | reported | 22 May 2008 | tx 34+152,500−52,000 |
| Salarius Pharmaceuticals, Inc. | 20,500 | reported | 20 Feb 2024 | tx 6+122,440 |
| Rallybio Corp | 4,115 | reported | 23 Feb 2026 | tx 6+547,500−789 |
| APPLIED GENETIC TECHNOLOGIES CORP | 0 | reported | 30 Nov 2022 | tx 4+356,700−356,700 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Feb 2026 | SALE | Rallybio Corp | 789 | 5.06 USD | anomaly |
| 18 Feb 2026 | GRANT_AWARD | Rallybio Corp | 2,500 | 0.00 USD | |
| 14 Feb 2025 | GRANT_AWARD | Rallybio Corp | 180,000 | 0.00 USD | deriv |
| 20 Feb 2024 | GRANT_AWARD | Salarius Pharmaceuticals, Inc. | 20,500 | 0.00 USD | deriv |
| 15 Feb 2024 | GRANT_AWARD | Rallybio Corp | 120,000 | 0.00 USD | deriv |
| 14 Mar 2023 | PURCHASE | Rallybio Corp | 5,000 | 5.21 USD | |
| 01 Feb 2023 | GRANT_AWARD | Rallybio Corp | 240,000 | 0.00 USD | deriv |
| 03 Jan 2023 | GRANT_AWARD | Salarius Pharmaceuticals, Inc. | 1,440 | 0.00 USD | |
| 30 Nov 2022 | OTHER | APPLIED GENETIC TECHNOLOGIES CORP | 154,700 | — | deriv |
| 30 Nov 2022 | OTHER | APPLIED GENETIC TECHNOLOGIES CORP | 202,000 | — | deriv |
| 21 Aug 2022 | GRANT_AWARD | APPLIED GENETIC TECHNOLOGIES CORP | 154,700 | 0.00 USD | deriv |
| 07 Jun 2022 | PURCHASE | Salarius Pharmaceuticals, Inc. | 37,500 | 0.19 USD | first after silence |
| 20 Jan 2022 | GRANT_AWARD | Salarius Pharmaceuticals, Inc. | 30,000 | 0.00 USD | deriv |
| 20 Sept 2021 | GRANT_AWARD | APPLIED GENETIC TECHNOLOGIES CORP | 202,000 | 0.00 USD | deriv |
| 02 Dec 2020 | GRANT_AWARD | Salarius Pharmaceuticals, Inc. | 30,000 | 0.00 USD | deriv |
| 14 Jul 2020 | GRANT_AWARD | Salarius Pharmaceuticals, Inc. | 3,000 | 0.00 USD | deriv |
| 01 Oct 2018 | OTHER | Ocugen, Inc. | 28,000 | 0.00 USD | deriv |
| 01 Oct 2018 | GRANT_AWARD | Ocugen, Inc. | 110,000 | 0.00 USD | deriv |
| 01 Oct 2018 | OTHER | Ocugen, Inc. | 130,000 | 0.00 USD | deriv |
| 01 Oct 2018 | OTHER | Ocugen, Inc. | 30,000 | 0.00 USD | deriv |
| 01 Oct 2018 | GRANT_AWARD | Ocugen, Inc. | 130,000 | 0.00 USD | deriv |
| 01 Oct 2018 | GRANT_AWARD | Ocugen, Inc. | 28,000 | 0.00 USD | deriv |
| 01 Oct 2018 | OTHER | Ocugen, Inc. | 50,000 | 0.00 USD | deriv |
| 01 Oct 2018 | GRANT_AWARD | Ocugen, Inc. | 50,000 | 0.00 USD | deriv |
| 01 Oct 2018 | OTHER | Ocugen, Inc. | 110,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 07 Jun 2022.